Description
BPC-157 & TB-500 blend 10mg — two-peptide research vial
A single vial containing both BPC-157 and a synthetic thymosin beta-4 fragment, supplied as lyophilized powder at 99%+ purity at 99%+ purity for laboratory research. The blend exists because a good many published tissue-model protocols apply both compounds together, and preparing them from one vial removes a pipetting step and a source of ratio error.
Ships from within the USA. Supplied for laboratory research use only, and not for human or veterinary use.
About BPC-157 & TB-500 Blend 10mg
The two peptides act on different parts of the same experimental picture. BPC-157 work centers on fibroblast behavior, explant outgrowth and endothelial assays; TB-500 work centers on actin sequestration and the migration assays that depend on it. Studying them together is a way to look at whether the readouts are additive, redundant or in tension — a question that cannot be asked at all from single-compound data.
A blend carries one caveat worth stating plainly: a combined certificate reports the purity of each component, but a co-lyophilized vial cannot be split afterwards. If your design needs an arm with only one of the two, order the single-compound vials as well.
Research applications of BPC-157 & TB-500 Blend 10mg
- Combination protocols in tendon, ligament and connective tissue models
- Comparative work against single-compound arms run in parallel
- Fibroblast migration and scratch-wound assays
- Collagen and extracellular matrix studies in culture
- Endothelial and angiogenesis assays in vitro
How this vial is supplied and handled
The vial arrives as a lyophilized cake or film in a sealed, stoppered vial. Keep it sealed and frozen at -20 °C until the day it is opened; brief periods at ambient temperature in transit are expected and do not compromise dry powder. Let the vial reach room temperature before breaking the seal so atmospheric moisture does not condense onto the cake.
Reconstitute by running the diluent slowly down the inside wall of the vial rather than onto the powder, and swirl rather than shake — peptides denature at an air-liquid interface. Hold the solution at 2–8 °C for short-term use, or aliquot and freeze for longer, and avoid repeated freeze-thaw cycles, the most common cause of a quiet loss of activity between one experiment and the next.
Ordering BPC-157 & TB-500 BLEND 10mg in the United States
BPC-157 & TB-500 BLEND 10mg ships to research laboratories throughout the USA, dispatched domestically from our US facility. Every parcel is tracked, and because the material stays inside the country there is no customs entry, no broker fee and no border hold between our shelf and your bench.
Shipping is calculated at checkout and orders over $200 USD ship free anywhere in the United States. Bulk pricing is available on larger quantities — email us before checkout and we will quote it.
Purity guarantee
If an independent laboratory tests this material and reports purity below the figure stated on its certificate, we refund the order and reimburse what the test cost you. Send the lot number printed on the vial along with the third-party report and we will settle it without argument.
The guarantee covers the analysis, not the outcome of your work. What BPC-157 & TB-500 Blend 10mg does in your model is your experiment; what is in the vial is our responsibility.
COA: 3P Tested Purity Results: BPC-157 | 99.258% | 11.3 mg | View Test
Research use only
BPC-157 & TB-500 Blend 10mg is supplied strictly for laboratory research carried out by qualified professionals. It is not a drug, a dietary supplement or a medical device.
It has not been evaluated or approved by the U.S. Food and Drug Administration for any use. It is not for human or veterinary consumption, for clinical investigation in human subjects, or for therapeutic, diagnostic or cosmetic application of any kind.
We do not provide dosing, administration or protocol advice, and we cannot answer questions about use in people or animals. By ordering, you confirm that you are acquiring this material for lawful research in a controlled laboratory setting and that you will not redistribute it for any other purpose.
Compound identity and specification
BPC-157 & TB-500 BLEND 10mg is a blend, so identity is given per component. Each formula, mass and registry number below is verified against PubChem and can be looked up directly.
| Component | Sequence | Formula | Mass (g/mol) | CAS |
|---|---|---|---|---|
| TB-500 CID 62707662 | Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln (acetylated LKKTETQ, the thymosin beta-4 17-23 region) | C38H68N10O14 | 889.0 | 885340-08-9 |
| BPC-157 CID 9941957 | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV) | C62H98N16O22 | 1419.5 | 137525-51-0 |
| Total peptide content | 10 mg total — TB-500 5 mg, BPC-157 5 mg |
|---|---|
| Physical form | Lyophilized powder in a sealed vial |
| Analysis | Third-party HPLC on the single-compound BPC-157 and TB-500 vials; the blend itself has not been tested separately: Janoshik task #93626 (99.258% purity, 11.30 mg measured in the 10 mg vial); Janoshik task #93627 (99.165% purity, 10.84 mg measured in the 10 mg vial) |
| Supplied for | Laboratory research use only |
Analytical note — TB-500. TB-500 is the short acetylated fragment, not full-length thymosin beta-4, which is a 43-residue protein of about 4,963 g/mol. The two are routinely conflated. A mass near 889 confirms the fragment; a mass near 4,963 would be a different product entirely.
Identity references The molecular formula, molecular mass and CAS registry number above are taken from the PubChem record linked in the table, not from a supplier datasheet, so every figure can be checked against an independent source in one click. Sequences are given as reported in the peptide literature, in the one-letter or three-letter convention as appropriate, with any non-standard residue named in full. Where a compound exists in more than one form — a free peptide and a metal complex, a fragment and its parent protein, a modified and an unmodified analog — the form supplied is the one identified here, and the mass on the certificate of analysis is what distinguishes it.
Research Literature
Peer-reviewed studies involving this compound and its class. All findings listed are from in vitro, cell culture or animal models and are provided for scientific reference only. This product is supplied for laboratory research and is not approved for human consumption, clinical, or veterinary use.
- Bock-Marquette I, et al. Nature. 2004;432(7016):466-472. In embryonic mouse cardiomyocyte and endothelial culture and a mouse coronary artery ligation model, measured cell migration, myocyte survival and ILK/Akt kinase activity. Source · PMID 15565145
- Malinda KM, et al. FASEB J. 1997;11(6):474-481. In human umbilical vein endothelial cell (HUVEC) culture, measured directional chemotactic migration in Boyden-chamber assays. Source · PMID 9194528
- Philp D, et al. FASEB J. 2003;17(14):2103-2105. In HUVEC culture and chick aortic arch explants, measured migration, adhesion and vessel sprouting elicited by the LKKTETQ actin-binding motif at approximately 50 nM. Source · PMID 14500546
- Chang CH, et al. J Appl Physiol. 2011;110(3):774-780. In rat Achilles tendon explant culture and isolated tendon fibroblasts, measured explant outgrowth, fibroblast survival under oxidative stress, migration, and FAK/paxillin phosphorylation. Source · PMID 21030672
- Hsieh MJ, et al. J Mol Med (Berl). 2017;95(3):323-333. In chick chorioallantoic membrane assay, a rat hind-limb ischemia model and human endothelial cell culture, measured vessel density, endothelial tube formation and VEGFR2-Akt-eNOS phosphorylation. Source · PMID 27847966
- Chang CH, et al. Molecules. 2014;19(11):19066-19077. In primary tendon fibroblasts from Sprague-Dawley rat Achilles tendon, measured growth hormone receptor mRNA and protein levels, PCNA expression and JAK2 phosphorylation. Source · PMID 25415472
Literature notes: Published work concerns full-length thymosin beta-4 or its LKKTETQ actin-binding fragment. Equivalence between those and material marketed as TB-500 is not established in the literature. The published base for this compound is small and concentrated in a limited number of research groups, with little independent replication of in vivo findings.
Independent reports for this line: Janoshik task #93626 (99.258% purity, 11.30 mg measured in the 10 mg vial) and Janoshik task #93627 (99.165% purity, 10.84 mg measured in the 10 mg vial), covering the single-compound BPC-157 and TB-500 vials; the blend itself has not been tested separately. Every certificate we hold, with its laboratory verification key, is listed on the certificates of analysis page.
Related Research Compounds
Browse more compounds in BPC-157 & TB-500 Peptides, or view the full research peptide catalog.
BPC-157 10mg
NAD+ 1000mg
MOTS-c 10mg
Selank 10mg
Leigh (verified owner) –
Arrived on time and very professional looking labels with primo quality products… I’ve ordered from Exolabs a few times now and never had an issue… highly recommend A++.